LOAMU
NBSE

Lombard Odier Asset Management (USA)’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,144
Closed -$3.78M – 212
2014
Q4 		$3.82M Buy
1,144
+95
+9% +$291K 0.26% 104
2014
Q3 		$3.04M Buy
1,049
+299
+40% +$989K 0.21% 127
2014
Q2 		$2.85M Buy
+750
New +$2.82M 0.15% 139

Other funds holding NBSE

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
SIP
Stoneridge Investment Partners Radnor, Pennsylvania $152M AUM 20.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s NBSE Position: Q1 2015 in Review

Lombard Odier Asset Management (USA) sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q1 2015, closing a stake of 1,144 shares — an estimated $3.78M sold.

Lombard Odier Asset Management (USA) first reported a position in NBSE in Q2 2014 and held it in 3 quarters. The position peaked at $3.82M in Q4 2014. 64 funds tracked by Wall St. Rank hold NBSE as of Q1 2015.

  • Lombard Odier Asset Management (USA) reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Lombard Odier Asset Management (USA) sold 1,144 NeuBase Therapeutics, Inc. Common Stock shares in Q1 2015, an estimated $3.78M.
  • Lombard Odier Asset Management (USA) first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q2 2014 and held it in 3 quarters.
  • Lombard Odier Asset Management (USA)'s NeuBase Therapeutics, Inc. Common Stock position peaked at $3.82M in Q4 2014.
  • 64 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q1 2015.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2015, filed 15 May 2015.